Latest Announcements

Shadowfax Technologies Limited has announced its Q1 FY27 financial results, with revenue growing 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanding to 4.9%, and PAT reaching an all-time high of ₹65 Cr.

Strides Pharma Science Limited has announced its consolidated financial results for the quarter (Q1FY27) ended 30 June, 2026, with revenue at ₹12,654m, growing 13% YoY, and EBITDA at ₹2,298m, growing 5.4% YoY.

Shadowfax Technologies Ltd reported its Q1 FY27 performance, achieving record revenue, margins, and profitability. Revenue grew 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanded to 4.9%, and PAT reached an all-time high of ₹65 Cr.

Strides Pharma Science Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, to the National Stock Exchange of India and the Bombay Stock Exchange. The results were approved by the Board of Directors at their meeting held on July 31, 2026. The financial results are available on the company's website at www.strides.com.

Hybrid Financial Services Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a total income of Rs. 151.43 crores and a profit before tax of Rs. 58.22 crores. The company's principal business is stock broking and allied activities.

Aether Industries Limited has informed the Exchange about Investor Presentation, with Frequently Asked Questions (FAQs) on the presentation shared, including quarterly performance, site nomenclature, operations and supply chain, and capital expenditure.

Aether Industries Ltd reported strong quarterly sales growth of 27% YoY and 7% QoQ, driven by 75% YoY growth in Contract and Exclusive Manufacturing (CEM) and 20% YoY growth in Contract Research and Manufacturing Services (CRAMS). The company also provided an update on its manufacturing sites, with new names and a focus on diversification across sectors.

Aether Industries Limited has announced its Q1 FY27 financial results, showing a 27% YoY growth in operating revenue to ₹3,051 M, with a 31% YoY growth in EBITDA to ₹814 M and a 33% YoY growth in PAT to ₹540 M. The company has also provided an update on its R&D expansion plans, including the installation of 18 fume hoods and the construction of a new R&D building.

Aether Industries Ltd has announced its Q1 FY27 financial results, with a 27% YoY growth in operating revenue to ₹3,051 M, driven by growing CEM contracts and price-led LSM demand. The company has also reported a 31% YoY growth in EBITDA to ₹814 M, and a 33% YoY growth in profit after tax to ₹540 M.

Oriental Aromatics Limited has informed the Exchange about Earnings Call Presentation. The company has disclosed its Q1-FY27 consolidated financial performance, with sales volumes increasing by 22% YoY and EBITDA margin improving to 7.62%. The company has also highlighted its operational highlights, including production volumes growing by 18% YoY and a favourable product mix.

Bajaj Finserv Ltd's board meeting outcome for the quarter ended 30 June 2026 includes approval of unaudited standalone and consolidated financial results, issue of equity shares to Bajaj Finserv ESOP Trust, and approval for pursuing re-insurance business.

Share India Securities Limited has announced its Q1 FY 2027 earnings, with standalone revenue increasing by 28% YoY to Rs. 349 crores and profit after tax growing by 32% to Rs. 90.85 crore. The company's consolidated revenue from operation increased by 31% YoY to Rs. 448 crores, while profit after tax rose by 48% to Rs. 124.41 crore.

Mahindra & Mahindra Limited has published its unaudited consolidated and standalone financial results for the quarter ended 30th June 2026, showing a profit of Rs. 5,454.54 crores and Rs. 3,684.97 crores respectively, with a total income from operations of Rs. 58,187.57 crores and Rs. 41,958.76 crores respectively.

Share India Securities Ltd has announced its Q1 FY 2027 earnings, with standalone revenue increasing by 28% YoY to Rs. 349 crores and profit after tax growing by 32% to Rs. 90.85 crore. Consolidated revenue increased by 31% YoY to Rs. 448 crores, with consolidated PAT rising by 48% to Rs. 124.41 crore.

Mahindra & Mahindra Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended 30th June 2026, showing a total income from operations of Rs. 58,187.57 crore and a profit for the period of Rs. 5,454.54 crore.

Spandana Sphoorty Financial Ltd's Q1 FY27 earnings conference call transcript reveals a good quarter with AUM growth of 11% to INR4,887 crores, new member addition of 61%, and annualized credit cost at 2.1%. The company collected INR51 crores in the 90-plus pool and garnered INR545 crores in sanctions under the credit guarantee scheme. PAT was INR12 crores, up from INR5 crores in the March '26 quarter. The company is focusing on growth in Tamil Nadu and Maharashtra, and is piloting an individual loan product in 8 branches in Madhya Pradesh.

Spandana Sphoorty Financial Limited held an analysts/institutional investor meet/conference call to discuss Q1 FY27 earnings. Key highlights include an 11% QoQ growth in AUM to INR4,887 crores, new member addition of 61% and 1.38 lakh members, and a net credit cost of 2.1%. The company aims to double its share in Maharashtra and pilot an individual loan product in Madhya Pradesh.

Anlon Healthcare Limited has announced its unaudited Financial Results for Q1FY27, reporting a 163.02% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150.14% growth in EBITDA to ₹15.65 Crore, and 133.13% growth in Profit After Tax to ₹8.28 Crore. The company has strengthened its integrated pharmaceutical platform through strategic acquisitions, expanded its product portfolio, and improved operational synergies.

Anlon Healthcare Limited has reported a 163% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150% growth in EBITDA to ₹15.65 Crore, and 133% growth in Profit After Tax to ₹8.28 Crore for Q1FY27.

Data Patterns (India) Ltd has announced the submission of an investor presentation for Q1 FY 2026-27, highlighting its strong outlook and positioning across its portfolio, with a focus on delivering profitable growth and strong cash generation. The company has a robust order book, with Rs 9,277 Mn as on 30th June 2026, and is confident of growing its existing products and expects additional revenue generation by tapping the larger market opportunities from new developments.